Delirium as a predictor of long-term cognitive impairment in survivors of critical illness

grants/research funds from the National Institutes of Health. Dr. Pandharipande has disclosed that he received honoraria from Hospira, Inc, and GlaxoSmithKline; received grants/research funds from Hospira, Inc.; and is on the speaker’s bureau for France Foundation—CME organizers for Hospira Inc. Ms. Pun has disclosed that she was and is a consultant/advisor for Hospira, Inc. Dr. Ely has disclosed that he received and is currently receiving grants/research funds from Hospira, Pfizer, GlaxoSmithKline, and Aspect; was a consultant/advisor for Hospira, GlaxoSmithKline, and Aspect; was on the speaker’s bureau of Hospira, Pfizer, GlaxoSmithKline, and Aspect; and is a consultant/advisor for, and on the speaker’s bureau of, Hospira, Pfizer, GlaxoSmithKline, and Aspect. The remaining authors have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.